Big sale: $20.1M of Intellia Therapeutics Inc out of ARKK
ARKK did the selling. Plus the other trades that day and how ARK compares with the market.
Generated from ARK's own holdings data.
An estimated $20.1M of Intellia Therapeutics Inc (NTLA) was sold by ARKK on 21 Sep 2026. No other trade that day was bigger.
Money came into the funds that day, nudging every holding grew by roughly 16.9%. NTLA shrank 17%, far more than the rest — that difference is the actual decision.
This isn't a one-off. Across 23 trades in 30 days, ARK has sold a net $42.8M of the stock.
Everything ARK did on 21 Sep 2026
ARK made 1 real move that day, once money flowing in and out of the funds is stripped out:
| Stock | Funds | Est. value |
|---|---|---|
| NTLA Intellia Therapeutics IncSold 3 days running | ARKK | −$20.1M |
The bigger picture: ARK's last 30 days
Across the month, the money has gone mostly into Nvidia Corp ($53.0M), Rocket Lab ($44.4M), Broadcom Inc ($40.9M). The biggest sales over the same period: Advanced Micro Devices ($122.8M), Palantir Technologies Inc ($66.6M), Tempus AI Inc ($58.8M).
Is it working?
So far this year ARKK is winning — +18.0% against the S&P 500's +14.0%.
That five-year gap — 107 points — mostly comes down to timing. Five years ago ARKK was trading close to its all-time high of Feb 2021. It then fell 81% to its low in Dec 2022, and it is still 41% below that peak today. Any comparison that starts near the top of that boom looks brutal.
| To date | 1 month | YTD | 1 year | 5 years |
|---|---|---|---|---|
| ARKK | +5.8% | +18.0% | +11.2% | -21.2% |
| S&P 500 (SPY) | +0.9% | +14.0% | +18.5% | +85.8% |
| Nasdaq-100 (QQQ) | +4.8% | +21.5% | +25.9% | +105.3% |
How we work this out
ETFpeek is an independent research tool and is not affiliated with ARK Invest or Cathie Wood. Figures are estimates from public fund data, shown for information only — not financial advice. Past performance does not indicate future results.